Comparison of first- and second-wave DAAs for HCV GT1: efficacy, safety, tolerability, and regimen complexity HEPATOLOGY INTERNATIONAL Burman, B. E., Kwo, P. Y., Kowdley, K. V. 2014; 8 (3): 352-364

View details for DOI 10.1007/s12072-014-9552-6

View details for Web of Science ID 000339939700008

View details for PubMedID 26202638